AlgoraeOS
The facts below are what the maker publishes about AlgoraeOS, checked and dated. Our editors have not written about it yet.
The facts
Each one read from AlgoraeOS's own pages, with the date it was checked.
What it does
- Benchmarking
- The company says AOS2 outperformed representative state-of-the-art models in published benchmarks.checked 14 Nov 2026
- Closed-loop design
- Discovery and pre-clinical development data continuously feed back to strengthen the platform's predictive capability.checked 14 Nov 2026
- Current candidates
- The site identifies AI-116 and AI-168 as priority licensing candidates.checked 14 Nov 2026
- Data inputs
- The platform connects pre-clinical, clinical, chemical and biological data to generate drug-combination candidates.checked 14 Nov 2026
- Dose-response models
- AlgoraeOS models dose-response surfaces using Bliss, Loewe, HSA and ZIP.checked 14 Nov 2026
- Independent validation
- Independent wet-lab validation at Peter MacCallum Cancer Centre tested 21 drug-drug targets across four cancer cell lines, generating approximately 10,000 data points.checked 14 Nov 2026
- Intellectual property
- Algorae states that the platform's intellectual property is 100% owned by the company.checked 14 Nov 2026
- Licensing and co-development
- Validated candidates are available for out-licensing and co-development with pharmaceutical and biotech partners.checked 14 Nov 2026
- Prediction scale
- The platform has generated 500,000 drug-cell line predictions across 3,000+ drugs and 170 cancer cell lines.checked 14 Nov 2026
- Purpose
- AlgoraeOS is an AI-powered drug discovery platform that generates drug-combination candidates for licensing and co-development.checked 14 Nov 2026
- Research infrastructure
- The UNSW Data Science Hub provides data analysis tools and access to high-performance computing infrastructure for the collaboration.checked 14 Nov 2026
- Research partners
- Named research partners are UNSW AI Institute, CSIRO/Data61 and Peter MacCallum Cancer Centre.checked 14 Nov 2026
- Training data
- AlgoraeOS was trained on more than 5.5 million unique inhibition records, approximately 11 million with augmentation.checked 14 Nov 2026
The company
- Headquarters
- Algorae lists its address in Melbourne, Victoria, Australia.checked 14 Nov 2026
Alternatives to AlgoraeOS
- 1
Boltzmann Labs
Free planWebAPI6.7Free plan - 2
Amazon Bio Discovery
Free planWeb6.6From $180 a month - 3
TRION
Free planWebmacOSWindows6.3From $0.01 a month - 46.0Free plan
- 5
StarDrop
WebLinuxmacOSWindows5.7From $10,000 a year - 65.5From $2,500 a month
